Structure-activity relationships for halobenzene induced cytotoxicity in rat and human hepatoctyes

被引:36
作者
Chan, Katie
Jensen, Neil S.
Silber, Paul A.
O'Brien, Peter J.
机构
[1] Univ Toronto, Grad Dept Pharmaceut Sci, Fac Pharm, Toronto, ON M5S 3M2, Canada
[2] Vitro Technol, Baltimore, MD 21227 USA
关键词
QSAR; hepatocytes; bromobenzene; ACMS; xenobiotics; liver toxicity;
D O I
10.1016/j.cbi.2006.12.004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Halobenzenes are ubiquitous environmental contaminants, which are hepatotoxic in both rodents and humans. The molecular mechanism of hatobenzene hepatotoxicity was investigated using Quantitative structure-activity relationships (QSAR) and accelerated cytotoxicity mechanism screening (ACMS) techniques in rat and human hepatocytes. The usefulness of isolated hepatocytes for prediciting in vivo xenobiotic toxicity was reassessed by correlating the LC50 of 12 halobenzene congeners in phenobarbital (PB) induced rat hepatocytes in vitro determined by ACMS to the hepatotoxicities reported in vivo in PB-induced male Sprague-Dawely (SD) rats. A high correlation (r(2) = 0.90) confirmed the application of hepatocytes as a "gold standard" for toxicity testing in vitro. QSARs were derived to determine the physico-chemcial variables that govern hatobenzene toxicity in PB-induced rat, normal rat and human hepatocytes. We found that toxicity in normal rat and normal human hepatocytes both strongly correlate with hydrophobicity (log P), ease of oxidation (E-HOMO, energy of the highest molecular orbital) and on the asymmetric charge distribution according to arrangement of halogen substituents (dipole moment, mu). This suggests that halobenzene interaction with cytochrome P450 for oxidation is the metabolic activating path for toxicity and is similar in both species. In PB-induced rat hepatocytes the QSAR derivation is changed, where halobenzene toxicity strongly correlates to log P and dipole moment, but not E-HOMO. The changed QSAR suggests that oxidation is no longer the rate-limiting step in the cytotoxic mechanism when CYP2B/3A levels are increased, confirming CYP450 oxidation as the metabolic activating step under normal conditions. (c) 2006 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:165 / 174
页数:10
相关论文
共 34 条
[1]  
ARIYOSHI T, 1975, CHEM PHARM BULL, V23, P817
[2]   POSSIBLE MECHANISM OF LIVER NECROSIS CAUSED BY AROMATIC ORGANIC COMPOUNDS [J].
BRODIE, BB ;
REID, WD ;
CHO, AK ;
SIPES, G ;
KRISHNA, G ;
GILLETTE, JR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1971, 68 (01) :160-&
[3]  
CAMPBELL NRC, 1987, MOL PHARMACOL, V32, P813
[4]  
Cronin M.T.D., 2004, PREDICTING CHEM TOXI
[5]   THE LIVER, KIDNEY, AND THYROID TOXICITY OF CHLORINATED BENZENES [J].
DENBESTEN, C ;
VET, JJRM ;
BESSELINK, HT ;
KIEL, GS ;
VANBERKEL, BJM ;
BEEMS, R ;
VANBLADEREN, PJ .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1991, 111 (01) :69-81
[6]  
FISHER R, 1991, In Vitro Toxicology, V4, P173
[7]   CORRELATION OF METABOLISM, COVALENT BINDING AND TOXICITY FOR A SERIES OF BROMOBENZENE DERIVATIVES USING RAT-LIVER SLICES IN-VITRO [J].
FISHER, R ;
BRENDEL, K ;
HANZLIK, RP .
CHEMICO-BIOLOGICAL INTERACTIONS, 1993, 88 (2-3) :191-208
[8]  
Galati G, 2000, Drug Metabol Drug Interact, V17, P311
[9]   TOXICITY OF ORTHO-SUBSTITUTED BROMOBENZENES TO ISOLATED HEPATOCYTES - COMPARISON TO INVIVO RESULTS [J].
GOTTSCHALL, DW ;
WILEY, RA ;
HANZLIK, RP .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1983, 69 (01) :55-65
[10]  
Hansch C., 1995, EXPLORING QSAR